Stifel cuts COVID-19 vaccine developer Inovios price target as earnings and call leave more questions than answers – MarketWatch

Stifel analysts cut their stock rate target for Inovio Pharmaceuticals Inc
.
INO, -6.08%.
to $16 from $24 on Tuesday, after the company published a wider-than-expected second-quarter loss and reven … [+1543 chars]